Top Swiss court rules that recommended retail prices are anticompetitive

Switzerland’s highest court has ruled that Pfizer’s recommended price-lists for an erectile dysfunction drug restricted competition, in a decision that local competition lawyers say creates uncertainty about the legality of recommended resale prices.


Get unlimited access to all Global Competition Review content